Author:
Gumuser G.,Vural K.,Varol T.,Parlak Y.,Tuglu I.,Topal G.,Sayit E.
Publisher
Springer Science and Business Media LLC
Subject
Radiology Nuclear Medicine and imaging,General Medicine
Reference43 articles.
1. Akkas BE, Gokcora N, Atasever T, Yetkin I. The use of technetium-99m hexamethylpropylene amine oxime lung scintigraphy in the detection of subclinical lung injury in patients with noninsulin-dependent diabetes mellitus. Nucl Med Commun. 2011;32(12):1179–84.
2. Chang CT, Liu FY, Lin CC, Wang TY, Lee CC, Kao A. Usefulness of technetium-99m hexamethylpropylene amine oxime lung scan to detect subclinical lung injury in patients with noninsulin-dependent diabetes mellitus. J Diabetes Complicat. 2004;18:229–32.
3. Durak H, Kilinç O, Ertay T, Uçan ES, Kargi A, Kaya GC, et al. Tc-99m-HMPAO uptake by bronchoalveolar cells. Ann Nucl Med. 2003;17(2):107–13.
4. Kaya GC, Bekis R, Kirimca F, Ertay T, Kargi A, Gure A, et al. Use of tecnetium-99m HMPAO scintigraphy for detection of amiodarone lung toxicity in a rabbit model. Eur J Nucl Med. 2001;28:346–50.
5. Suga K, Uchisako H, Nishigauchi K, Shimizu K, Kume N, Yamada N, et al. Technetium-99-m-HMPAO as a marker of chemical and irradiation lung injury. Experimental and clinical investigations. J Nucl Med. 1994;35:1520–7.
Cited by
6 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献